INVO Bioscience (INVO) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free INVO Stock Alerts $0.98 -0.19 (-16.23%) (As of 05:12 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media INVO Bioscience Short Interest DataCurrent Short Volume17,600 sharesPrevious Short Volume12,100 sharesChange Vs. Previous Month+45.45%Dollar Volume Sold Short$13,499.20Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares2,740,000 sharesFloat Size2,720,000 sharesShort Percent of Float0.65%Today's Trading Volume596,771 sharesAverage Trading Volume3,019,183 sharesToday's Volume Vs. Average20% Short Selling INVO Bioscience ? Sign up to receive the latest short interest report for INVO Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINVO Short Interest Over TimeINVO Days to Cover Over TimeINVO Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… INVO Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202417,600 shares $13,499.20 +45.5%0.7%0 $0.77 3/31/202412,100 shares $13,673.00 +10.0%0.5%0.4 $1.13 3/15/202411,000 shares $11,330.00 -1.8%0.5%0.4 $1.03 2/29/202411,200 shares $12,880.00 -24.3%0.5%0.2 $1.15 2/15/202414,800 shares $12,551.88 -32.4%0.6%0.1 $0.85 1/31/202421,900 shares $21,900.00 +2.3%0.9%0 $1.00 Get the Latest News and Ratings for INVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/15/202421,400 shares $22,470.00 -51.0%0.9%0 $1.05 12/31/202343,700 shares $58,995.00 -24.4%1.8%0 $1.35 12/15/202357,800 shares $71,094.00 -70.6%N/A0 $1.23 11/30/2023196,700 shares $367,829.00 -80.3%N/A0.1 $1.87 11/15/2023997,200 shares $1.84 million +245.1%N/A0.3 $1.85 10/31/2023289,000 shares $375,700.00 +397.4%N/A0.2 $1.30 10/15/202358,100 shares $39,827.55 -52.7%N/A0 $0.69 9/30/2023122,700 shares $96,957.54 +740.4%N/A0.6 $0.79 9/15/202314,600 shares $15,184.00 -13.6%N/A0.1 $1.04 8/31/202316,900 shares $25,519.00 -86.7%N/A0.1 $1.51 8/15/2023127,400 shares $181,545.00 +182.5%N/A0.5 $1.43 7/31/202345,100 shares $223,696.00 -84.5%N/A0.2 $4.96 7/15/2023290,600 shares $51,145.60 -38.8%N/A0.2 $0.18 6/30/2023474,800 shares $95,054.96 +363.2%3.2%0.4 $0.20 6/15/2023102,500 shares $17,404.50 +94.5%0.8%0.1 $0.17 5/31/202352,700 shares $13,417.42 -28.6%0.4%0.1 $0.25 5/15/202373,800 shares $26,095.68 No Change0.6%0.4 $0.35 10/31/202259,200 shares $68,080.00 -17.2%N/A2.4 $1.15 10/15/202271,500 shares $88,660.00 +3.6%N/A2.8 $1.24 9/30/202269,000 shares $73,140.00 +102.9%N/A2.6 $1.06 9/15/202234,000 shares $49,640.00 +38.8%N/A1 $1.46 8/31/202224,500 shares $23,716.00 -63.6%N/A0.8 $0.97 8/15/202267,300 shares $76,049.00 +3.9%N/A1.5 $1.13 7/31/202264,800 shares $64,152.00 +19.8%N/A1.4 $0.99 7/15/202254,100 shares $51,936.00 -30.7%N/A1.1 $0.96 6/30/202278,100 shares $49,976.19 +65.5%N/A1.5 $0.64 6/15/202247,200 shares $41,819.20 -42.1%N/A0.9 $0.89 5/31/202281,500 shares $79,829.25 +13.5%N/A1.5 $0.98 5/15/202271,800 shares $101,956.00 +22.5%N/A1.9 $1.42 4/30/202258,600 shares $88,486.00 -34.0%N/A1.7 $1.51 4/15/202288,800 shares $166,944.00 -1.0%N/A2.1 $1.88 3/31/202289,700 shares $236,808.00 +27.1%N/A2.2 $2.64 3/15/202270,600 shares $154,614.00 +2.3%N/A1.6 $2.19 2/28/202269,000 shares $207,690.00 +63.5%N/A1.5 $3.01top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… INVO Short Interest - Frequently Asked Questions What is INVO Bioscience's current short interest? Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 17,600 shares of INVO short. 0.65% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest. What is a good short interest percentage for INVO Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.65% of INVO Bioscience's floating shares are currently sold short. Is INVO Bioscience's short interest increasing or decreasing? INVO Bioscience saw a increase in short interest in April. As of April 15th, there was short interest totaling 17,600 shares, an increase of 45.5% from the previous total of 12,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INVO Bioscience's float size? INVO Bioscience currently has issued a total of 2,740,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 2,720,000 shares. How does INVO Bioscience's short interest compare to its competitors? 0.65% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to INVO Bioscience: Minerva Surgical, Inc. (92.12%), ProSomnus, Inc. (1.18%), Aethlon Medical, Inc. (1.31%), Nemaura Medical Inc. (0.34%), Tenon Medical, Inc. (1.82%), Dynatronics Co. (0.58%), Assure Holdings Corp. (2.04%), Sharps Technology, Inc. (2.47%), Quoin Pharmaceuticals, Ltd. (0.41%), ReShape Lifesciences Inc. (2.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short INVO Bioscience stock? Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. INVO shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INVO Bioscience? A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further. How often is INVO Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: UTRS Short Interest OSA Short Interest AEMD Short Interest NMRD Short Interest TNON Short Interest DYNT Short Interest IONM Short Interest STSS Short Interest QNRX Short Interest RSLS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INVO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings